Brewin Dolphin Wealth Management LTD Magenta Therapeutics, Inc. Put Options Transaction History

Brewin Dolphin Wealth Management LTD

  • $917 Million
  • Q2 2022

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email